Tirzepatide was the first Health Canada-authorized peptide drug to activate both GIP and GLP-1 receptors with one molecule
GIP receptor agonism provides insulin sensitization in adipose tissue, enhanced nutrient-stimulated insulin secretion (complementing the GLP-1 component), potential direct CNS effects on appetite regulation, and improved adipose tissue lipid handling and metabolism
Whilst Ozempic's primary indication remains diabetes treatment, clinical trials have revealed additional metabolic effects beyond glucose control
Injections of miR-141-3p agomir, miR-411 mimics, miR-9, miR-21 lentivirus, miR-26a, miRNA-147 mimics have been proven to ameliorate cartilage injury and bone erosion, further inhibiting inflammatory arthritic development in CIA animal models (223, 226, 229, 230, 284)
Nauck, M
Cell and Mol Life Sci